GENE ONLINE|News &
Opinion
Blog

2025-11-27|

Study Explores Physicians’ Views on AI in Hospital Management Highlighting Efficiency and Data Privacy Concerns

by GOAI
Share To

A recent study conducted by researchers Zhou, Jomhari, and Farid examines physicians’ perspectives on the use of artificial intelligence (AI) in hospital management systems. The qualitative research highlights key attitudes and concerns among medical professionals as AI technologies become increasingly integrated into healthcare administration. The findings shed light on how physicians view the potential benefits, challenges, and implications of adopting AI in managing hospital operations.

The study explores various aspects of AI implementation, including its potential to streamline administrative tasks, improve efficiency, and enhance decision-making processes. It also identifies reservations expressed by physicians regarding data privacy, ethical considerations, and the reliability of AI systems in critical healthcare settings. By analyzing these viewpoints, the research provides insight into the factors influencing acceptance or resistance to AI adoption within hospital environments. This study contributes to ongoing discussions about balancing technological advancements with human oversight in healthcare management.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top